Ticker
GRCECompany Name
GRACE THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Cash and Equivalents | Cash Ratio | Current Liabilities |
---|---|---|---|
6/30/2025 | $ 20M | 8.64 | $ 2.31M |
3/31/2025 | $ 22.13M | 11.47 | $ 1.93M |
12/31/2024 | $ 11.05M | 5.61 | $ 1.97M |
9/30/2024 | $ 15.15M | 5.67 | $ 2.67M |
6/30/2024 | $ 19.39M | 7.46 | $ 2.6M |
3/31/2024 | $ 23M | 13.66 | $ 1.68M |
12/31/2023 | $ 18.55M | 10.48 | $ 1.77M |
9/30/2023 | $ 26.99M | 19.32 | $ 1.4M |
6/30/2023 | $ 21.63M | 11 | $ 1.97M |
3/31/2023 | $ 27.88M | 8.17 | $ 3.41M |
CashnEq / LiabilitesC
(=) Cash Ratio
Cash Ratio for GRACE THERAPEUTICS INC is calculated as follows: CashnEq [ $ 11.55M ] / LiabilitesC [ $ 3.75M ]
(=) Cash Ratio [ 3.08 ]
Minimum
Sep 30, 2020
Maximum
Mar 31, 2021
Average
Median
filtered constituents | 3.13K |
---|---|
min | 0 |
max | 2.69 |
average | 0.62 |
median | 0.39 |
std | 0.63 |